AU2021231205B2 - Composition for use in a treatment of cervical cell abnormalities comprising selenite compound and acid - Google Patents
Composition for use in a treatment of cervical cell abnormalities comprising selenite compound and acidInfo
- Publication number
- AU2021231205B2 AU2021231205B2 AU2021231205A AU2021231205A AU2021231205B2 AU 2021231205 B2 AU2021231205 B2 AU 2021231205B2 AU 2021231205 A AU2021231205 A AU 2021231205A AU 2021231205 A AU2021231205 A AU 2021231205A AU 2021231205 B2 AU2021231205 B2 AU 2021231205B2
- Authority
- AU
- Australia
- Prior art keywords
- asc
- change
- lsil
- agc
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gynecology & Obstetrics (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20160817.1 | 2020-03-03 | ||
| EP20160817.1A EP3875083A1 (en) | 2020-03-03 | 2020-03-03 | Composition for use in a treatment of cervical cell abnormalities comprising selenite compound and acid |
| PCT/EP2021/055230 WO2021175877A1 (en) | 2020-03-03 | 2021-03-03 | Composition for use in a treatment of cervical cell abnormalities comprising selenite compound and acid |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2021231205A1 AU2021231205A1 (en) | 2022-09-01 |
| AU2021231205B2 true AU2021231205B2 (en) | 2026-02-26 |
Family
ID=69770560
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2021231205A Active AU2021231205B2 (en) | 2020-03-03 | 2021-03-03 | Composition for use in a treatment of cervical cell abnormalities comprising selenite compound and acid |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US20230092142A1 (https=) |
| EP (2) | EP3875083A1 (https=) |
| JP (1) | JP7840859B2 (https=) |
| CN (1) | CN115279358A (https=) |
| AR (1) | AR122387A1 (https=) |
| AU (1) | AU2021231205B2 (https=) |
| BR (1) | BR112022017436A2 (https=) |
| CL (1) | CL2022002363A1 (https=) |
| CY (1) | CY1126764T1 (https=) |
| ES (1) | ES2976058T3 (https=) |
| HR (1) | HRP20240374T1 (https=) |
| HU (1) | HUE066384T2 (https=) |
| IL (1) | IL296146A (https=) |
| MA (1) | MA58262B1 (https=) |
| MD (1) | MD4084788T2 (https=) |
| MX (1) | MX2022010838A (https=) |
| PL (1) | PL4084788T3 (https=) |
| RS (1) | RS65349B1 (https=) |
| SM (1) | SMT202400126T1 (https=) |
| TW (1) | TW202146004A (https=) |
| UA (1) | UA130108C2 (https=) |
| WO (1) | WO2021175877A1 (https=) |
| ZA (1) | ZA202208848B (https=) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012109685A1 (de) * | 2011-02-16 | 2012-08-23 | Selo Medical Gmbh | Pharmazeutische zubereitung enthaltend selenit - oder selenithaltige verbindungen zur behandlung von cervix - dysplasien oder -karzinomen |
| WO2020043762A1 (en) * | 2018-08-28 | 2020-03-05 | Selo Medical Gmbh | Therapy of high-risk human papillomavirus infections |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2406377C (en) | 2000-05-10 | 2010-07-06 | Okopharm Forschungs-Und Entwicklungs-Gmbh | Method for reducing the surface area of silicon dioxide |
| AT412758B (de) | 2000-06-05 | 2005-07-25 | Vis Vitalis Lizenz & Handels | Verwendung einer selenithältigen lösung zur behandlung viraler erkrankungen |
| AT412703B (de) | 2001-12-04 | 2005-06-27 | Vis Vitalis Lizenz & Handels | Verwendung von selenithältigen präparaten zur topischen oder bukkalen anwendung |
-
2020
- 2020-03-03 EP EP20160817.1A patent/EP3875083A1/en not_active Withdrawn
-
2021
- 2021-02-20 TW TW110105956A patent/TW202146004A/zh unknown
- 2021-03-02 AR ARP210100542A patent/AR122387A1/es unknown
- 2021-03-03 MX MX2022010838A patent/MX2022010838A/es unknown
- 2021-03-03 ES ES21709400T patent/ES2976058T3/es active Active
- 2021-03-03 MA MA58262A patent/MA58262B1/fr unknown
- 2021-03-03 IL IL296146A patent/IL296146A/en unknown
- 2021-03-03 HU HUE21709400A patent/HUE066384T2/hu unknown
- 2021-03-03 UA UAA202203621A patent/UA130108C2/uk unknown
- 2021-03-03 JP JP2022551024A patent/JP7840859B2/ja active Active
- 2021-03-03 BR BR112022017436A patent/BR112022017436A2/pt unknown
- 2021-03-03 PL PL21709400.2T patent/PL4084788T3/pl unknown
- 2021-03-03 CN CN202180017791.7A patent/CN115279358A/zh active Pending
- 2021-03-03 SM SM20240126T patent/SMT202400126T1/it unknown
- 2021-03-03 RS RS20240372A patent/RS65349B1/sr unknown
- 2021-03-03 EP EP21709400.2A patent/EP4084788B1/en active Active
- 2021-03-03 WO PCT/EP2021/055230 patent/WO2021175877A1/en not_active Ceased
- 2021-03-03 HR HRP20240374TT patent/HRP20240374T1/hr unknown
- 2021-03-03 AU AU2021231205A patent/AU2021231205B2/en active Active
- 2021-03-03 MD MDE20221247T patent/MD4084788T2/ro unknown
- 2021-03-03 US US17/905,145 patent/US20230092142A1/en active Pending
-
2022
- 2022-08-08 ZA ZA2022/08848A patent/ZA202208848B/en unknown
- 2022-08-30 CL CL2022002363A patent/CL2022002363A1/es unknown
-
2024
- 2024-03-27 CY CY20241100221T patent/CY1126764T1/el unknown
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012109685A1 (de) * | 2011-02-16 | 2012-08-23 | Selo Medical Gmbh | Pharmazeutische zubereitung enthaltend selenit - oder selenithaltige verbindungen zur behandlung von cervix - dysplasien oder -karzinomen |
| WO2020043762A1 (en) * | 2018-08-28 | 2020-03-05 | Selo Medical Gmbh | Therapy of high-risk human papillomavirus infections |
Also Published As
| Publication number | Publication date |
|---|---|
| US20230092142A1 (en) | 2023-03-23 |
| EP3875083A1 (en) | 2021-09-08 |
| RS65349B1 (sr) | 2024-04-30 |
| CL2022002363A1 (es) | 2023-03-31 |
| JP7840859B2 (ja) | 2026-04-06 |
| ES2976058T3 (es) | 2024-07-22 |
| EP4084788A1 (en) | 2022-11-09 |
| WO2021175877A1 (en) | 2021-09-10 |
| CY1126764T1 (el) | 2026-02-25 |
| ZA202208848B (en) | 2024-09-25 |
| AU2021231205A1 (en) | 2022-09-01 |
| CN115279358A (zh) | 2022-11-01 |
| BR112022017436A2 (pt) | 2022-10-18 |
| EP4084788B1 (en) | 2024-02-14 |
| TW202146004A (zh) | 2021-12-16 |
| CA3167015A1 (en) | 2021-09-10 |
| MD4084788T2 (ro) | 2024-06-30 |
| IL296146A (en) | 2022-11-01 |
| MA58262B1 (fr) | 2024-03-29 |
| PL4084788T3 (pl) | 2024-06-03 |
| UA130108C2 (uk) | 2025-11-12 |
| JP2023516153A (ja) | 2023-04-18 |
| AR122387A1 (es) | 2022-09-07 |
| HUE066384T2 (hu) | 2024-07-28 |
| SMT202400126T1 (it) | 2024-05-14 |
| EP4084788C0 (en) | 2024-02-14 |
| MX2022010838A (es) | 2022-09-27 |
| HRP20240374T1 (hr) | 2024-06-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20250281524A1 (en) | Therapy of high-risk human papillomavirus infections | |
| AU2014338707A1 (en) | Treatment of cancer and benign proliferative disorders | |
| Syrjanen et al. | Human papillomavirus (HPV) type as an important determinant of the natural history of HPV infections in uterine cervix | |
| AU2021231205B2 (en) | Composition for use in a treatment of cervical cell abnormalities comprising selenite compound and acid | |
| CA3167015C (en) | Composition for use in a treatment of cervical cell abnormalities comprising selenite compound and acid | |
| Facio Jr et al. | Clinical and molecular profile of patients with condyloma acuminatum treated in the Brazilian public healthcare system | |
| HK40074763B (en) | Composition for use in a treatment of cervical cell abnormalities comprising selenite compound and acid | |
| HK40074763A (en) | Composition for use in a treatment of cervical cell abnormalities comprising selenite compound and acid | |
| EA048159B1 (ru) | Композиция для применения в лечении аномалий цервикальных клеток, содержащая селенитовое соединение и кислоту | |
| HK40045218A (en) | Therapy of high-risk human papillomavirus infections | |
| HK40045218B (en) | Therapy of high-risk human papillomavirus infections | |
| EA048333B1 (ru) | Терапия папилломавирусных инфекций человека высокого риска | |
| EA042677B1 (ru) | Терапия папилломавирусных инфекций человека высокого риска | |
| Huber et al. | and Pedro-Antonio Regidor3 |